The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689898 | PMC |
| http://dx.doi.org/10.1093/cid/ciab930 | DOI Listing |
Publication Analysis
Top Keywords
severe acute
8
acute respiratory
8
respiratory syndrome
8
syndrome coronavirus
8
coronavirus messenger
8
messenger rna
8
allogeneic hematopoietic
8
hematopoietic stem
8
stem cell
8
cell transplant
8
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!